Kestra Advisory Services LLC Has $894,000 Position in BlackRock Health Sciences Term Trust $BMEZ

Kestra Advisory Services LLC increased its holdings in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZFree Report) by 3,561.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 62,246 shares of the company’s stock after purchasing an additional 60,546 shares during the period. Kestra Advisory Services LLC’s holdings in BlackRock Health Sciences Term Trust were worth $894,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of BMEZ. Geneos Wealth Management Inc. acquired a new stake in BlackRock Health Sciences Term Trust during the 1st quarter worth approximately $40,000. Allworth Financial LP lifted its stake in BlackRock Health Sciences Term Trust by 24,584.6% in the third quarter. Allworth Financial LP now owns 3,209 shares of the company’s stock valued at $46,000 after buying an additional 3,196 shares in the last quarter. CWM LLC boosted its holdings in shares of BlackRock Health Sciences Term Trust by 25.6% in the fourth quarter. CWM LLC now owns 3,336 shares of the company’s stock valued at $50,000 after buying an additional 680 shares during the period. Spirepoint Private Client LLC acquired a new position in shares of BlackRock Health Sciences Term Trust in the fourth quarter valued at approximately $154,000. Finally, Prospera Financial Services Inc acquired a new position in shares of BlackRock Health Sciences Term Trust in the fourth quarter valued at approximately $179,000.

BlackRock Health Sciences Term Trust Price Performance

Shares of BMEZ stock opened at $15.32 on Friday. BlackRock Health Sciences Term Trust has a 12-month low of $13.67 and a 12-month high of $15.80. The firm has a fifty day moving average of $14.82 and a 200-day moving average of $14.73.

BlackRock Health Sciences Term Trust Dividend Announcement

The business also recently announced a monthly dividend, which will be paid on Wednesday, September 30th. Investors of record on Tuesday, September 15th will be paid a $0.11 dividend. The ex-dividend date of this dividend is Tuesday, September 15th. This represents a c) dividend on an annualized basis and a yield of 8.6%.

About BlackRock Health Sciences Term Trust

(Free Report)

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.

Read More

Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZFree Report).

Institutional Ownership by Quarter for BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.